Imagion Biosystems Limited (ASX:IBX)
Australia · Delayed Price · Currency is AUD 0.0150
0.00 (0.00%)
Jul 30, 2025, 10:24 AM AEST
ATSG Market Cap
Imagion Biosystems has a market cap or net worth of 3.02 million as of August 1, 2025. Its market cap has increased by 32.16% in one year.
Market Cap
3.02M
Enterprise Value
3.20M
Revenue
2.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since June 22, 2017, Imagion Biosystems's market cap has decreased from 32.65M to 3.02M, a decrease of -90.75%. That is a compound annual growth rate of -25.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 3.02M | -34.78% |
| Dec 31, 2024 | 4.63M | -60.04% |
| Dec 29, 2023 | 11.59M | -56.93% |
| Dec 30, 2022 | 26.91M | -68.41% |
| Dec 31, 2021 | 85.20M | -41.15% |
| Dec 31, 2020 | 144.76M | 1,032.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.27B |
| Pro Medicus | 33.40B |
| Cochlear | 20.72B |
| Sonic Healthcare | 13.69B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 7.00B |
| Ansell | 4.38B |
| Mesoblast | 3.13B |